Literature DB >> 14699446

Possible evidence for a common risk locus for bipolar affective disorder and schizophrenia on chromosome 4p16 in patients from the Faroe Islands.

T D Als1, H A Dahl, T J Flint, A G Wang, M Vang, O Mors, T A Kruse, H Ewald.   

Abstract

Patients with schizophrenia (n=11) and bipolar affective disorder (n=17) from the relatively isolated population of the Faroe Islands were genotyped for 34 polymorphic markers on chromosome 4 in a search for allelic association and haplotype sharing among distantly related patients. When considering bipolar patients only, there was no clearcut support for any region on chromosome 4. The two-marker segment D4S394-D4S2983 at 4p16.1 was, however, supported by a P-value of 0.0162. For patients with schizophrenia, there was reasonable support for 4p16.1 as marker D4S2281 (P=0.0019), a two-marker segment (D4S2281-D4S1605, P=0.0009) and a three-marker segment (D4S2923-D4S2928-D4S1582, P-0.0005) appeared to be associated with schizophrenia, with some alleles/haplotypes occurring with different frequencies in patients compared to controls. When combining both psychiatric disorders, chromosome 4p16.1 received further support from five partially overlapping two- and three-marker segments (D4S394-D4S2983, P=0.0039; D4S2281-D4S1605, P=0.0027 and D4S394-D4S2983-D4S2923, P=0.006; D4S2923-D4S2928-D4S1582, P=0.00007; D4S1582-D4S1599-D4S2281, P=0.005). Increased haplotype sharing in patients with schizophrenia and in the combined data set was partly supported by Fisher's exact test and tests based on the genealogy. Our study yields support for a common risk gene for schizophrenia and bipolar affective disorder on the short arm of chromosome 4, as suggested by previous findings in the neighbouring Scottish population.

Entities:  

Mesh:

Year:  2004        PMID: 14699446     DOI: 10.1038/sj.mp.4001393

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  8 in total

1.  Common variations in 4p locus are related to male completed suicide.

Authors:  Anne Must; Sulev Kõks; Eero Vasar; Gunnar Tasa; Aavo Lang; Eduard Maron; Marika Väli
Journal:  Neuromolecular Med       Date:  2008-12-25       Impact factor: 3.843

2.  Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin.

Authors:  Anton Terasmaa; Ursel Soomets; Julia Oflijan; Marite Punapart; Mats Hansen; Vallo Matto; Kersti Ehrlich; Anne Must; Sulev Kõks; Eero Vasar
Journal:  J Physiol Biochem       Date:  2011-04-02       Impact factor: 4.158

3.  Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder.

Authors:  Colin A Hodgkinson; David Goldman; Judith Jaeger; Shalini Persaud; John M Kane; Robert H Lipsky; Anil K Malhotra
Journal:  Am J Hum Genet       Date:  2004-09-22       Impact factor: 11.025

4.  Effect of chronic valproic Acid treatment on hepatic gene expression profile in wfs1 knockout mouse.

Authors:  Marite Punapart; Mall Eltermaa; Julia Oflijan; Silva Sütt; Anne Must; Sulev Kõks; Leonard C Schalkwyk; Catherine Fernandes; Eero Vasar; Ursel Soomets; Anton Terasmaa
Journal:  PPAR Res       Date:  2014-04-01       Impact factor: 4.964

5.  Aggregation of the protein TRIOBP-1 and its potential relevance to schizophrenia.

Authors:  Nicholas J Bradshaw; Verian Bader; Ingrid Prikulis; Angelika Lueking; Stefan Müllner; Carsten Korth
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

6.  Genomic view of bipolar disorder revealed by whole genome sequencing in a genetic isolate.

Authors:  Benjamin Georgi; David Craig; Rachel L Kember; Wencheng Liu; Ingrid Lindquist; Sara Nasser; Christopher Brown; Janice A Egeland; Steven M Paul; Maja Bućan
Journal:  PLoS Genet       Date:  2014-03-13       Impact factor: 5.917

7.  The Faroese IBD Study: Incidence of Inflammatory Bowel Diseases Across 54 Years of Population-based Data.

Authors:  Turid Hammer; Kári R Nielsen; Pia Munkholm; Johan Burisch; Elsebeth Lynge
Journal:  J Crohns Colitis       Date:  2016-03-01       Impact factor: 9.071

8.  LDB2 locus disruption on 4p16.1 as a risk factor for schizophrenia and bipolar disorder.

Authors:  Yasue Horiuchi; Tomoe Ichikawa; Tetsuo Ohnishi; Yoshimi Iwayama; Kazuya Toriumi; Mitsuhiro Miyashita; Izumi Nohara; Nanako Obata; Tomoko Toyota; Takeo Yoshikawa; Masanari Itokawa; Makoto Arai
Journal:  Hum Genome Var       Date:  2020-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.